Cargando…
Type IV collagen as a potential biomarker of metastatic breast cancer
No reliable, non-invasive biomarker of metastatic breast cancer (mBC) exists: circulating CA15-3 (cCA15-3) is the marker mostly used to monitor mBC. Circulating collagen IV (cCOLIV) has been evaluated in other metastatic cancers and has been found to be a promising biomarker. The overarching aim of...
Autores principales: | Lindgren, Moa, Jansson, Malin, Tavelin, Björn, Dirix, Luc, Vermeulen, Peter, Nyström, Hanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987628/ https://www.ncbi.nlm.nih.gov/pubmed/33655422 http://dx.doi.org/10.1007/s10585-021-10082-2 |
Ejemplares similares
-
Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement
por: Nyström, Hanna, et al.
Publicado: (2015) -
Type IV Collagen in Human Colorectal Liver Metastases—Cellular Origin and a Circulating Biomarker
por: Lindgren, Moa, et al.
Publicado: (2022) -
Prognostic Value of Stromal Type IV Collagen Expression in Small Invasive Breast Cancers
por: Jansson, Malin, et al.
Publicado: (2022) -
Laminin-5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma Malignancy
por: Oldak, Lukasz, et al.
Publicado: (2022) -
Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management
por: van Schooneveld, Eleni, et al.
Publicado: (2015)